Description
Developer of a biochemical test designed to offer early diagnosis of autism. The company's test develops therapies and detects autism from a drop of blood, enabling doctors to treat medical needs of patients with a Autism.
Contact Information
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
3. Out of Business | 31-Mar-2020 | 00000 | Completed | Out of Business | ||
2. Early Stage VC | 22-Dec-2014 | 00000 | 00000 | 00.00 | Completed | Startup |
1. Grant | Completed | Startup |
Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
---|---|---|---|---|---|---|---|---|
Ordinary | 0,000 | 00.000000 | 000.00 | 000.00 | 00 | 000.00 | 00.000 |
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
AU-2011341776-A1 | Novel biomarker and uses thereof in diagnosis, treatment of autism | Granted | 16-Dec-2010 | 00000000000 | |
CA-2821908-C | Novel biomarker and uses thereof in diagnosis, treatment of autism | Expired - Fee Related | 16-Dec-2010 | 00000000000 | |
AU-2011341776-B2 | Novel biomarker and uses thereof in diagnosis, treatment of autism | Ceased | 16-Dec-2010 | 00000000000 | |
JP-2014506244-A | Biomarkers and their use in the diagnosis and treatment of autism | Granted | 16-Dec-2010 | 00000000000 | 0 |
JP-5960717-B2 | Biomarkers and their use in the diagnosis and treatment of autism | Expired - Fee Related | 16-Dec-2010 | G01N33/6896 |